English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
雲頂新耀宣佈增加對I-Mab的戰略投資 開發自研新一代腫瘤免疫療法的全球價值
Aug 01, 2025 23:48 HKT
云顶新耀宣布增加对I-Mab的战略投资 开发自研新一代肿瘤免疫疗法的全球价值
Aug 01, 2025 23:45 HKT
Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence
Jul 29, 2025 16:00 HKT
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 04:00 HKT
維立志博於聯交所主板成功上市
Jul 25, 2025 19:36 HKT
维立志博于联交所主板成功上市
Jul 25, 2025 18:00 HKT
亿胜生物多剂量地夸磷索钠滴眼液获中国国家药品监督管理局批准上市
Jul 25, 2025 10:52 HKT
億勝生物多劑量地誇磷索鈉滴眼液獲中國國家藥品監督管理局批准上市
Jul 25, 2025 10:52 HKT
Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China
Jul 25, 2025 10:52 HKT
云顶新耀宣布配售股份 拟集资约15.725亿港元
Jul 25, 2025 10:01 HKT
雲頂新耀宣布配售股份 擬集資約15.725億港元
Jul 25, 2025 10:01 HKT
Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million
Jul 25, 2025 10:01 HKT
아반토코리아, 수원 사무실 광교중앙역 인근으로 이전
Jul 24, 2025 09:00 HKT
Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration
Jul 24, 2025 09:00 HKT
冠科生物圣地亚哥实验室获 CLIA 认证 增强临床试验支持能力
Jul 23, 2025 09:00 HKT
冠科生物聖地牙哥實驗室獲 CLIA 認證 增強臨床試驗支援能力
Jul 23, 2025 09:00 HKT
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
Jul 22, 2025 13:00 HKT
康哲药业携手新交所 共话新兴市场产业国际化与医药出海新范式探索
Jul 18, 2025 13:00 HKT
AATec Medical 与 Northway Biotech 宣布合作开发用于治疗肺部疾病的 ATL-105 工业化生产工艺
Jul 16, 2025 09:00 HKT
AATec Medical 與 Northway Biotech 宣布合作開發用於治療肺部疾病的 ATL-105 工業化生產工藝
Jul 16, 2025 09:00 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: